IFNA1 and head and neck squamous cell carcinoma: HNSCC-derived EVs can not only release a variety of antitumour inflammatory factors (IFN, CD40/80/86 and CXCL) but also upregulate the expression of NAP1 and IRF-3 in NK cells, which play an important role in mediating antitumour immunity [117].